LCAM
NVS icon

London & Capital Asset Management’s Novartis NVS Stock Holding History

London & Capital Asset Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,288
Closed -$287K – 94
2020
Q2 		$287K Buy
+3,288
New +$284K 0.05% 90

Other funds holding NVS

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

London & Capital Asset Management's NVS Position: Q3 2020 in Review

London & Capital Asset Management sold out of Novartis (NVS) in Q3 2020, closing a stake of 3,288 shares — an estimated $287K sold.

London & Capital Asset Management first reported a position in NVS in Q2 2020 and held it in 1 quarter. The position peaked at $287K in Q2 2020. 1,119 funds tracked by Wall St. Rank hold NVS as of Q3 2020.

  • London & Capital Asset Management reported no remaining Novartis position as of Q3 2020 after selling out during the quarter.
  • London & Capital Asset Management sold 3,288 Novartis shares in Q3 2020, an estimated $287K.
  • London & Capital Asset Management first reported a position in Novartis in Q2 2020 and held it in 1 quarter.
  • London & Capital Asset Management's Novartis position peaked at $287K in Q2 2020.
  • 1,119 funds tracked by Wall St. Rank held Novartis as of Q3 2020.

Based on London & Capital Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.